Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical cardiology"
DOI: 10.1002/clc.24059
Abstract: Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid pathway. The goal in managing FH is to reduce circulating low-density lipoprotein cholesterol and, therefore, reduce the risk of developing atherosclerotic cardiovascular… read more here.
Keywords: access cardiovascular; covid pandemic; familial hypercholesterolemia;